FIELD: chemistry.
SUBSTANCE: invention relates to the use of coagulating compositions mainly containing extracted or at least partially purified snake venom prothrombin activator, as well as to containers containing the said coagulating compositions and to related methods of the use.
EFFECT: use of coagulating compositions has been proposed.
14 cl, 69 dwg, 75 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS FOR TREATMENT OF COAGULOPATHIES WITH APPLICATION OF SULPHATED POLYSACCHARIDES | 2005 |
|
RU2347574C2 |
| METHOD FOR DETECTING BLOOD CLOTTING FACTOR DEFICIENCY BY THROMBOELASTOMETRY | 2019 |
|
RU2699798C1 |
| METHOD OF CONTROLLING ANTICOAGULANT THERAPY | 2012 |
|
RU2607658C2 |
| METHOD FOR DETERMINING FIBRINOGEN DURING RECALCIFICATION OF CITRATE PLASMA AND EVALUATING ITS FUNCTIONALITY | 2019 |
|
RU2703541C1 |
| METHOD AND APPARATUS FOR PRODUCING SERUM WITH THROMBIN FROM ONE DONOR | 2013 |
|
RU2589648C2 |
| DIRECT THROMBIN INHIBITOR, POSSESSING ANTIPROLIFERATIVE ACTION | 2007 |
|
RU2369615C2 |
| DIAGNOSTICS OF THROMBOEMBOLIC VEIN DISEASES BY DETERMINATION OF CONTENT OF D-DIMERS AND SOLUBLE FIBRIN | 2007 |
|
RU2475760C2 |
| DETERMINING OF CIRCULATING THROMBIN IN COMPLEMENT ACTIVATION TEST | 2019 |
|
RU2709341C1 |
| DNA-APTAMERS INTERACTING WITH PROTHROMBIN | 2018 |
|
RU2703799C1 |
| METHOD FOR DETERMINING THE FUNCTIONAL ACTIVITY OF ANTITHROMBIN III IN BLOOD PLASMA | 2021 |
|
RU2772195C1 |
